This webinar will concentrate on the emerging research across novel precision prevention approaches.  The session will highlight not only agents currently under investigation in cancer prevention studies—such as cancer prevention vaccines and therapeutic agents but also those primarily used for other indications, which are showing growing evidence of a cancer preventive role. The subsequent panel discussion will focus on exploring knowledge gaps, challenges, opportunities and the incentives required in advancing precision prevention approaches on the road to implementation for patient/public benefit. The goal of the webinar is to showcase the importance of innovation in precision primary prevention, highlighting the future potential in the field.